NephroGenex shares rocket after lead drug found safe for heart

(Reuters) - Shares of NephroGenex Inc shot up nearly nine-fold in premarket trading, a day after the drug developer said its lead drug was found to be safe in a cardiac safety study. The oral drug, pyridorin, is being evaluated in a late-stage study in patients with diabetic nephropathy - a chronic, degenerative kidney disease caused by diabetes, which is often accompanied by heart disease. Cardiac safety concerns have been seen with other therapies in development, the company said late on Tuesday. ...



via Health News Headlines - Yahoo News http://news.yahoo.com/nephrogenex-shares-rocket-lead-drug-found-safe-heart-135048879--finance.html